Time to be positive about negative data?
作者信息
Vincent T, Malfait A-M
机构信息
Arthritis Research UK Centre for OA Pathogenesis, Kennedy Institute of Rheumatology, University of Oxford, Roosevelt Drive, Oxford OX3 7FY, UK.
Department of Internal Medicine, Division of Rheumatology & Department of Biochemistry, Rush University Medical Center, 1611 W. Harrison St, Suite 510, Chicago, IL 60612, USA.
出版信息
Osteoarthritis Cartilage. 2017 Mar;25(3):351-353. doi: 10.1016/j.joca.2017.01.016.
Abstract
摘要
相似文献
1
Time to be positive about negative data?
Osteoarthritis Cartilage. 2017 Mar;25(3):351-353. doi: 10.1016/j.joca.2017.01.016.
2
[The dance about the "impact factor"].
Ugeskr Laeger. 2007 Jun 11;169(24):2317.
3
[The profit roundabout].
Tidsskr Nor Laegeforen. 2007 May 3;127(9):1173.
4
[Clinical medical research--from wrong to worse?].
Tidsskr Nor Laegeforen. 2003 Jan 23;123(2):142.
5
Assessment of publication bias for the surgeon scientist.
Br J Surg. 2008 Aug;95(8):943-9. doi: 10.1002/bjs.6302.
6
Uptake of methods to deal with publication bias in systematic reviews has increased over time, but there is still much scope for improvement.
J Clin Epidemiol. 2011 Apr;64(4):349-57. doi: 10.1016/j.jclinepi.2010.04.022.
7
Publication bias as a function of study characteristics.
Psychol Methods. 2015 Sep;20(3):310-30. doi: 10.1037/met0000046.
8
Null is beautiful: On the importance of publishing null results.
J Psychopharmacol. 2016 Jul;30(7):585. doi: 10.1177/0269881116638813.
9
Publication bias in the anesthesiology literature.
Anesth Analg. 2012 May;114(5):1042-8. doi: 10.1213/ANE.0b013e3182468fc6. Epub 2012 Feb 17.
10
Conflicts of interest may bias research into sugary drinks and obesity.
BMJ. 2014 Jan 2;348:f7654. doi: 10.1136/bmj.f7654.
引用本文的文献
1
Effects of Terpenes on the Osteoarthritis Cytokine Profile by Modulation of IL-6: Double Face versus Dark Knight?
Biology (Basel). 2023 Jul 28;12(8):1061. doi: 10.3390/biology12081061.
2
Challenges and opportunities of pharmacological interventions for osteoarthritis: A review of current clinical trials and developments.
Osteoarthr Cartil Open. 2021 Sep 8;3(4):100212. doi: 10.1016/j.ocarto.2021.100212. eCollection 2021 Dec.
3
Of mice and men: converging on a common molecular understanding of osteoarthritis.
Lancet Rheumatol. 2020 Oct;2(10):e633-e645. doi: 10.1016/S2665-9913(20)30279-4. Epub 2020 Sep 23.
4
Molecular and structural imaging in surgically induced murine osteoarthritis.
Osteoarthritis Cartilage. 2020 Jul;28(7):874-884. doi: 10.1016/j.joca.2020.03.016. Epub 2020 Apr 16.
5
IL-1 in osteoarthritis: time for a critical review of the literature.
F1000Res. 2019 Jun 21;8. doi: 10.12688/f1000research.18831.1. eCollection 2019.
本文引用的文献
1
Role of the C-C chemokine receptor-2 in a murine model of injury-induced osteoarthritis.
Osteoarthritis Cartilage. 2017 Jun;25(6):914-925. doi: 10.1016/j.joca.2016.11.004. Epub 2016 Nov 14.
2
Considerations for the design and execution of protocols for animal research and treatment to improve reproducibility and standardization: "DEPART well-prepared and ARRIVE safely".
Osteoarthritis Cartilage. 2017 Mar;25(3):354-363. doi: 10.1016/j.joca.2016.10.016. Epub 2016 Nov 2.
3
CCL2 and CCR2 regulate pain-related behaviour and early gene expression in post-traumatic murine osteoarthritis but contribute little to chondropathy.
Osteoarthritis Cartilage. 2017 Mar;25(3):406-412. doi: 10.1016/j.joca.2016.10.008. Epub 2016 Oct 13.
4
Interleukin-1 is not involved in synovial inflammation and cartilage destruction in collagenase-induced osteoarthritis.
Osteoarthritis Cartilage. 2017 Mar;25(3):385-396. doi: 10.1016/j.joca.2016.09.009. Epub 2016 Sep 18.
5
Considerations for the design, analysis and presentation of in vivo studies.
Osteoarthritis Cartilage. 2017 Mar;25(3):364-368. doi: 10.1016/j.joca.2016.06.023. Epub 2016 Jul 30.
6
Upregulation of Atrogin-1/FBXO32 is not necessary for cartilage destruction in mouse models of osteoarthritis.
Osteoarthritis Cartilage. 2017 Mar;25(3):397-400. doi: 10.1016/j.joca.2016.07.008. Epub 2016 Jul 30.
7
Upregulation of lipocalin-2 (LCN2) in osteoarthritic cartilage is not necessary for cartilage destruction in mice.
Osteoarthritis Cartilage. 2017 Mar;25(3):401-405. doi: 10.1016/j.joca.2016.07.009. Epub 2016 Jul 29.
8
ADAMTS-5 takes centre stage in new developments for aggrecanase inhibitors.
Osteoarthritis Cartilage. 2015 Aug;23(8):1231-2. doi: 10.1016/j.joca.2015.05.023. Epub 2015 May 28.
9
Lack of a chondroprotective effect of cyclooxygenase 2 inhibition in a surgically induced model of osteoarthritis in mice.
Arthritis Rheum. 2012 Jan;64(1):198-203. doi: 10.1002/art.33324.
10
Double-knockout of ADAMTS-4 and ADAMTS-5 in mice results in physiologically normal animals and prevents the progression of osteoarthritis.
Arthritis Rheum. 2007 Nov;56(11):3670-4. doi: 10.1002/art.23027.
Zotero 插件